Bio-Rad Reports First-Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bio-Rad Labs (BIO) PT Lifted to $165 at Jefferies
May 6, 2015 8:09 AM EDTJefferies analyst Brandon Couillard reiterated a Buy rating and lifted his price target on Bio-Rad Labs (NYSE: BIO) to $165.00 (from $150.00) following much better-than-expected Q1 results.
Couillard commented, "BIO's 1Q15 EPS of $0.61 dusted our view ($0.36) on vastly better profitability, despite a sizable... More
Bio-Rad Labs (BIO) Tops Q1 EPS by 28c
May 5, 2015 4:41 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $472.8 million versus the consensus estimate of $474.6 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
... More